Breaks Categories: News

TuesdayJun 29, 2021 11:13 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Receives FDA Fast Track Status for Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the U.S. Food and Drug Administration granted Fast Track Designation for Berubicin, the company’s lead investigational drug. The status was received for the company’s evaluation of Berubicin for the treatment of patients with recurrent glioblastoma multiforme (“GBM”). An anthracycline, Berubicin falls in a class of anticancer agents that are among the most powerful chemotherapy drugs, proven to be effective against more types of cancer than any other category of chemotherapeutic agents. Fast…

Continue Reading

TuesdayJun 29, 2021 10:16 am

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Issues Statement on Continued Commitment to High Compliance Standards in ENDS Industry

Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI(R) Stick disposable electronic nicotine delivery system ("ENDS"), intended exclusively for adults 21 and over. Kaival Brands today issued a statement prioritizing its compliance with the Tobacco Control Act and the PACT Act. “First and foremost, our chief concern and priority is continuing to prevent youth access to Bidi Vapor products,” said Kaival Brands CEO Niraj “Raj” Patel in the press release. “We are parents and run our company with youth prevention as a priority. These increased precautions add levels of protection…

Continue Reading

TuesdayJun 29, 2021 10:11 am

NetworkNewsBreaks – Gratomic Inc. (TSX.V: GRAT) (OTCQX: CBULF) (FRANKFURT: CB82) Completes Acquisition Agreement Regarding Aukam Property

Gratomic (TSX.V: GRAT) (OTCQX: CBULF) (FRANKFURT: CB82), has finalized a definitive agreement outlining its acquisition of Next Graphite Inc.’s 37% interest in Gazania Investments Two Hundred and Forty Two (Proprietary) Limited, a Namibian company that holds licenses on the Aukam property. According to the agreement, which was first announced in November 2020, Gratomic will hold 100% of the rights and interests in the Aukam Mining License and exploration License. Next Graphite noted that combining the interests in Aukam provides an opportunity to optimize the potential of Aukam and allow Next Graphite shareholders to participate in the success of Gratomic; the…

Continue Reading

TuesdayJun 29, 2021 10:08 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Launches High Times Branded Vapes Throughout Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced the successful launch of High Times branded vapes into the Michigan market. Building on RWB’s partnerships and the successful launch of High Times branded packaged flower and pre-rolls earlier in the year, the company is pleased to introduce the High Times branded vapes, offered as premium live resin and distillate cartridges. The High Times branded vapes and previously launched products are available at 22 of Michigan’s finest dispensaries, while the High Times branded product portfolio will be made available to…

Continue Reading

MondayJun 28, 2021 3:36 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP), WPD Pharmaceuticals to Soon Recruit Patients for Combined Berubicin Clinical Studies

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, sublicenses the compound Berubicin to WPD Pharmaceuticals for 30 countries mainly in Europe and Asia. WPD, a clinical-stage pharmaceutical company, today provided an update on its Berubicin drug candidate clinical development program for the treatment of glioblastoma multiforme (“GBM”). According to the update, WPD plans to commence its Phase Ib/II Study of Berubicin in the treatment of glioblastoma in the second half of 2021. In addition, CNS Pharmaceuticals has announced open enrollment in the…

Continue Reading

MondayJun 28, 2021 3:14 pm

NetworkNewsBreaks – InvestorBrandNetwork Heightening Visibility, Widening Reach of Roth Capital Partners’ Healthcare Private Company Forum

InvestorBrandNetwork (“IBN”), an innovative corporate communications firm and content distributor, today announced that it is continuing its collaboration with Roth Capital Partners (“Roth”) for its Virtual Healthcare Private Company Forum. The event is shining the spotlight on a diverse selection of companies across biotechnology, pharmaceuticals and medical technologies verticals and featuring engaging discussion panels designed to offer novel insights into some of the latest developments within the healthcare space. The panels will cover a number of topics, including “Novel Approaches to Tumor Eradication,” “Natural Killer Cell Approaches to Eradicate Tumors,” and the “Next Wave of Psychedelic Drug Developers.” IBN, operating in the capacity of…

Continue Reading

MondayJun 28, 2021 2:45 pm

NetworkNewsBreaks – Airbnb Inc. (NASDAQ: ABNB) Featured in Bloomberg Wealth Article

Airbnb (NASDAQ: ABNB), a San Francisco, California-based vacation rental and online marketplace company, was featured in a recent Bloomberg article titled, “Investors Chasing Housing Target Massive Pools of Airbnb Rentals.” The piece discusses a new strategy investors are tapping in their hunt for returns in the frenzied U.S. real estate market. “Emboldened by a post-pandemic travel boom and searching for better returns than they can get in hotels or apartment buildings, other firms are building on the strategies employed by the scrappy entrepreneurs who built small portfolios of short-term rentals and helped drive Airbnb Inc.’s decade-long rise,” the article reads. “Plans to…

Continue Reading

MondayJun 28, 2021 1:56 pm

NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Added to Russell Microcap(R) Index

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art components and semiconductor chips for satellite and 5G communications networks, defense, space, and other commercial applications, today announced that it has joined the Russell Microcap(R) Index. The addition is in conjunction with the index’s annual reconstitution, which took effect after the market’s close on June 25, 2021. “Inclusion in the Russell Microcap Index is a testament to the progress we have made positioning AmpliTech to participate in the build-out of satellite networks, 5G communications and other next-generation networks,” said AMPG CEO Fawad Maqbool. “These systems will provide enhanced data…

Continue Reading

MondayJun 28, 2021 1:01 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Options Gold-Copper Endowed Project in Sought-After Metal Belt

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced its entry into an earn-in agreement. Under the agreement, GoldHaven may earn a 100% interest in the 4,190-hectare Smoke Mountain copper-gold property located in central British Columbia approximately 60 kilometers southwest of Houston and 23 km north-northwest of Imperial Metals Corporation’s copper-molybdenum-silver Huckleberry Mine. Per the update, the property is accessible via a series of gravel forest service roads off Highway 16. “The Smoke Mountain Project provides GoldHaven’s shareholders with access to a gold-copper endowed project…

Continue Reading

MondayJun 28, 2021 12:32 pm

NetworkNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Names New Chief Integration Officer, Fifth & Root GM

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a premier consumer-driven cannabis company formerly known as Golden Leaf Holdings Ltd., has announced the appointment of a new member of management. Ginger Mollo will served as chief integration office for Chalice Brands and general manager for Fifth & Root; a nationally recognized CBD skincare brand. In her new roles, Mollo will oversee positioning and growing the Fifth & Root Brand within the health and wellness beauty market in addition to integrating the products within the Chalice brands. A veteran in retail and company development, Mollo has worked at companies such as Limited Brands…

Continue Reading